We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Live Images of Growing Tumors Reveals Cancer’s Hidden Mechanisms

By LabMedica International staff writers
Posted on 25 Sep 2013
Print article
Image: The new imaging tool reveals strikingly different networks of blood vessels surrounding different types of tumors in a mouse model. Left: breast cancer in the breast. Middle: metastatic breast cancer in the brain. Right: ectopic breast cancer in the skin (Photo courtesy of Nature Medicine).
Image: The new imaging tool reveals strikingly different networks of blood vessels surrounding different types of tumors in a mouse model. Left: breast cancer in the breast. Middle: metastatic breast cancer in the brain. Right: ectopic breast cancer in the skin (Photo courtesy of Nature Medicine).
Image: A tumor before (left) and five days after (right) anti-angiogenic treatment--a novel treatment approach by inhibiting blood vessel growth skin (Photo courtesy of Nature Medicine).
Image: A tumor before (left) and five days after (right) anti-angiogenic treatment--a novel treatment approach by inhibiting blood vessel growth skin (Photo courtesy of Nature Medicine).
A group of researchers has developed a novel new optical imaging tool that enables them to look deep within tumors and reveal their inner processes, helping them to understand the slight, frequently concealed, changes to DNA, cells, proteins, and tissue that alter the body’s healthy biochemistry and cause disease.

In research that will be presented at Frontiers in Optics (FiO), the Optical Society’s (OSA) annual meeting, to be held October 6–10, 2013, in Orlando (FL, USA), Dr. Dai Fukumura and his colleagues will present new optical imaging technology designed to track the movement of molecules, cells, and fluids within tumors; study abnormalities in the blood vessel network inside them; and observe how the tumors were affected by treatments.

These techniques, created by Dr. Fukumura and his long-term collaborators at Massachusetts General Hospital (MGH; Boston, MA, USA) and Harvard Medical School (Boston, MA, USA), combine two different high-tech optical imaging methods that were personalized for the research purposed. One approach is called multiphoton laser-scanning microscopy (MPLSM), which is a sophisticated fluorescence imaging technology that is now commercially available at the high end of the microscope market. The other is called optical frequency domain imaging (OFDI), which images tissues by their light scattering characteristics. OFDI is gaining acceptance in the optical imaging field but has not yet to become commercially available, according to Dr. Fukumura. “MPLSM overcomes many of the limitations from which conventional microscopy and confocal microscopy suffer, and OFDI provides robust large volume imaging data,” Dr. Fukumura said.

At FiO 2013, Dr. Fukumura will describe how his unique technique can image tumors completely, and show detailed pictures of live tumors—images that he and colleagues call “astonishing.” He noted that while the new integrated tool would be too costly to be used for regular diagnostic purposes, it has the potential to help scientists better figure out the obscure mechanisms of human cancer and aid in drug discovery for cancer therapy. “These optical imaging approaches can provide unprecedented insights in the biology and mechanisms of cancer,” he concluded.


Related Links:
Massachusetts General Hospital
Harvard Medical School

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.